About
Peter Embi has spent his career at the intersection of medicine and informatics: coining the term "algorithmovigilance," serving as the nation's first Chief Research Information Officer, and leading AI work at Vanderbilt. He is also a patient. A rare adrenal tumor took nearly 15 years and a self-diagnosis to catch, and it nearly killed him. In this conversation, Embi connects that diagnostic odyssey to the case for monitoring clinical AI the way we monitor drugs: continuously, in the real world, across a network of institutions. The discussion runs from zebras and missed diagnoses to VAMOS, the "air traffic control tower" his team built to keep deployed models honest.